Table 8.
Mean (and SD) on efficacy measures pre- and post-treatment in Study 3.
| Measures | Pre |
Post 2 weeks |
Repeated measures ANOVA |
||||
|---|---|---|---|---|---|---|---|
| VR-S | Imag-S | VR-S | Imag-S | Time F (1,23) | Cond F (1,23) | Interaction F (1,23) | |
| CPGI | 19.86 (3.84) | 20.09 (2.55) | 11.21 (9.64) | 10.82 (8.32) | 19.62*** | 0.002 | 0.02 |
| DIG (n. Dx criteria) | 7.00 (1.96) | 8.00 (0.82) | 1.29 (1.20) | 1.10 (1.66) | 193.08*** | 0.91 | 1.71 |
| GRCS-total | 81.36 (27.09) | 87.18 (24.33) | 30.07 (7.62) | 26.18 (4.33) | 131.69*** | 0.03 | 0.99 |
Intent-to-treat data, ***p < 0.001.
VR-S, experimental condition where the urge is induced by stimuli recreated in virtual reality; Imag-S, control condition where the urge is induced by stimuli evoked in imagination; CPGI, Canadian Problem Gambling Index; DIG, Diagnostic Interview of Gambling (number of diagnostic criteria met by the participant); GRCS, Gambling Related Cognitions Scale.